Go to content
UR Home

Esters of bendamustine are by far more potent cytotoxic agents than the parent compound against human sarcoma and carcinoma cells

URN to cite this document:
urn:nbn:de:bvb:355-epub-312384
DOI to cite this document:
10.5283/epub.31238
Huber, Stefan ; Huettner, Johannes Philip ; Kristina, Hacker ; Bernhardt, Günther ; König, Jörg ; Buschauer, Armin
[img]
Preview
PDF
(1MB)
Date of publication of this fulltext: 09 Jul 2015 08:11


Abstract

The alkylating agent bendamustine is approved for the treatment of hematopoietic malignancies such as non-Hodgkin lymphoma, chronic lymphocytic leukemia and multiple myeloma. As preliminary data on recently disclosed bendamustine esters suggested increased cytotoxicity, we investigated representative derivatives in more detail. Especially basic esters, which are positively charged under ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons